Safety and Tolerability Study for T-1101 (Tosylate) Capsules to Treat Advanced Refractory Solid Tumors

Clinical trial NCT04685473 · COMPLETED

Trial details

NCT number: NCT04685473
Sponsor: Taivex Therapeutics Corporation
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Refractory Solid Tumors

Start date: 2021-01-07
Primary completion: 2025-04-11
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.